Kunitomo K, Hirano T, Tsuji T.

Numerous Schistocytes in thrombotic thrombocytopenic purpura.

https://pubmed.ncbi.nlm.nih.gov/33095337/

Mitsuhiro Uchiba, Masao Matsuoka.

Using weighted harmonic mean for prediction of APTT in the mixing test.

Thrombosis Update.

Volume 8, August 2022, 100114.

https://www.sciencedirect.com/science/article/pii/S2666572722000189?via%3Dihub

Tamanoi D, Saruwatari K, Imamura K, Sato R, Jodai T, Hamada S, Tomita Y, Saeki S, Ueno S, Yonemura Y, Ichiyasu H, Sakagami T.

case of pembrolizumab-related immune thrombocytopenia in a patient with lung adenocarcinoma treated by radiotherapy: potential immune-related adverse event elicited by radiation therapy.

Internal Med 61(11):1731-1734,2022. doi: 10.2169/internalmedicine.

https://pubmed.ncbi.nlm.nih.gov/34776479/

Kawano Y, Hata H, Takashio S, Tsujita K, Ueda M, Matsuoka M.

Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma

Br J Haematol ,2022. doi: 10.1111/bjh.18234. Online ahead of print.

https://pubmed.ncbi.nlm.nih.gov/35524546/

Ghosh AK, Kovela S, Sharma A, Shahabi D, Ghosh AK, Hopkins DR, Yadav M, Johnson ME, Agniswamy J, Wang YF, Hattori SI, Higashi-Kuwata N, Aoki M, Amano M, Weber IT, Mitsuya H.

Design, Synthesis and X-ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-furofuran Derivatives as P2 Ligands.

ChemMedChem doi: 10.1002/cmdc.202200058,2022.  doi: 10.1002/cmdc.202200058.

https://pubmed.ncbi.nlm.nih.gov/35170223/

Rajib S.A, Ogi Y, Hossain M.B, Ikeda T, Tanaka E, Kawaguchi T, Satou Y.

A SARS-CoV-2 Delta variant containing mutation in the probe binding regions used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result.

J Infect Chemother 28(5):669-677,2022. doi: 10.1016/j.jiac.2022.01.019

https://pubmed.ncbi.nlm.nih.gov/35144878/

Ikezoe T, Noji H, Ueda Y, Kanda Y, Okamoto S, Usuki K, Matsuda T, Akiyama H, Shimono A, Yonemura Y, Kawaguch T, Chiba S, Kanakura Y, Nishimura J, Ninomiya H, Obara N.

Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab:post-marketing surveillance in Japan.

Int J Hematol 115(4):470-480,2022. doi: 10.1007/s12185-022-03287-y.

https://pubmed.ncbi.nlm.nih.gov/35146630/

Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Iguchi D, Izutsu K.

Two-year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia.

Cancer Sci online ahead of print (DOI:10.1111/cas.15344)

https://pubmed.ncbi.nlm.nih.gov/35332633/

Inoue Y, Nishimura N, Murai M, Matsumoto M, Watanabe M, Yamada A, Izaki M, Nosaka K, Matsuoka M.

Prevention of acute graft-versus-host disease in adult T-cell leukemia-lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation.

Int J Hematol 115(3):435-9,2022.  doi: 10.1007/s12185-021-03250-3.

https://pubmed.ncbi.nlm.nih.gov/34705226/

Onishi C, Nishikori M, Yakushijin K, Kurahashi S, Nakazawa H, Takamatsu Y, Hashimoto Y, Tatetsu H, Nawa Y, Yoshida M, Kobayashi T, Oyake T, Yano S, Oride A, Suzuki R.

Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study.

Int J Hematol 115(3):382-390,2022. doi: 10.1007/s12185-021-03281-w.

https://pubmed.ncbi.nlm.nih.gov/34981434/

Nosaka K, Crawford B, Yi J, Kuan W, Matsumoto T, Takahashi T.

Systematic review of survival outcomes for relapsed or refractory adult T-cell leukemia-lymphoma.

Eur J Haematol 108(3):212-222,2022.  doi: 10.1111/ejh.13728.

https://pubmed.ncbi.nlm.nih.gov/34862665/

Zhao T, Wang Z, Fang J, Chengc W, Zhang Y, Huang J, Xu L, Zeng L, Jin Z, and Matsuoka M.

HTLV-1 activates YAP by NF-κB/p65 to promote oncogenesis.

Proc Natl Acad Sci USA  119(9):e2115316119,2022. doi: 10.1073/pnas.2115316119.

https://pubmed.ncbi.nlm.nih.gov/35210364/

Shichijo T, Tatetsu H, Nosaka K, Higuchi Y, Kikukawa Y, Inoue Y, Toyoda K, Yasunaga JI, Matsuoka M.

Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphoma.

eJHaem 1–9,2022.

https://onlinelibrary.wiley.com/doi/10.1002/jha2.393

Fuchida S, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Transplant Cell Ther 28(2):76-82,2022.  doi: 10.1016/j.jtct.2021.10.021.

https://pubmed.ncbi.nlm.nih.gov/34774818/

Fuchida SI, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Transplant Cell Ther 28(2):76-82,2022. doi: 10.1016/j.jtct.2021.10.021

https://pubmed.ncbi.nlm.nih.gov/34774818/

Kogure Y, Kameda T, Koya J, Yoshimitsu M, Nosaka K, Yasunaga JI, Imaizumi Y, Watanabe M, Saito Y, Ito Y, McClure MB, Tabata M, Shingaki S, Yoshifuji K, Chiba K, Okada A, Kakiuchi N, Nannya Y, Kamiunten A, Tahira Y, Akizuki K, Sekine M, Shide K, Hidaka T, Kubuki Y, Kitanaka A, Hidaka M, Nakano N, Utsunomiya A, Sica RA, Acuna-Villaorduna A, Janakiram M, Shah UA, Ramos JC, Shibata T, Takeuchi K, Takaori-Kondo A, Miyazaki Y, Matsuoka M, Ishitsuka K, Shiraishi Y, Miyano S, Ogawa S, Ye BH, Shimoda K, Kataoka K.

Whole-genome landscape of adult T-cell leukemia/lymphoma.

Blood 139(7):967-982,2022. doi: 10.1182/blood.2021013568.

https://pubmed.ncbi.nlm.nih.gov/34695199/

Nosaka K, Kusumoto S, Nakano N, Choi I, Yoshimitsu M, Imaizumi Y, Hidaka M, Sasaki H, Makiyama J, Ohtsuka E, Jo T, Ogata M, Ito A, Yonekura K, Tatetsu H, Kato T, Kawakita T, Suehiro Y, Ishitsuka K, Iida S, Matsutani T, Utsunomiya A, Ueda R, Ishida T.

Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukemia-lymphoma patients receiving mogamulizumab.

Br J Haematol 196(3):629-638,2022. doi: 10.1111/bjh.17895. Epub 2021 Oct 10.

https://pubmed.ncbi.nlm.nih.gov/34632569/

Higuchi Y, Yasunaga JI, Matsuoka M.

HTLV-1’s foxy strategy for survival and Transmission.

Front Virol doi: 10.3389/fviro.2021.792659,2022.

https://www.frontiersin.org/articles/10.3389/fviro.2021.792659/full

Masayuki Amano, Ravikiran S Yedidi, Pedro Miguel Salcedo-Gómez, Hironori Hayashi, Kazuya Hasegawa, Cuthbert D Martyr, Arun K Ghosh, Hiroaki Mitsuya.

Fluorine-Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier (BBB) Penetration Property of Novel Central Nervous System (CNS)-targeting HIV-1 Protease Inhibitors In Vitro.

Antimicrob Agents Chemother. 2022 Jan 3; AAC0171521. doi: 10.1128/AAC.01715-21.

https://journals.asm.org/doi/10.1128/AAC.01715-21

https://pubmed.ncbi.nlm.nih.gov/34978889/

Kawano Y, Sasano T, Arima Y, Kushima S, Tsujita K, Matsuoka M, Hata H.

A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells.

Biochem Biophys Res Commun 587: 153-159,2022. doi: 10.1016/j.bbrc.2021.11.102.

https://pubmed.ncbi.nlm.nih.gov/34875534/

Inoue Y, Nakano N, Fuji S, Eto T, Kawakita T, Suehiro Y, Miyamoto T, Sawayama Y, Uchida N, Kondo T, Kanda J, Atsuta Y, Fukuda T, Yoshimitsu M, Kato K, ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Impact of conditioning intensity and regimen on transplant outcomes in patients with adult T-cell leukemia-lymphoma.

Bone Marrow Transplant 56(12):2964-2974,2021.  doi: 10.1038/s41409-021-01445-0.

https://pubmed.ncbi.nlm.nih.gov/34462567/

Hiyoshi M, Takahashi N, Eltalkhawy YM, Noyori O, Lotfi S, Panaampon J, Okada S, Tanaka Y, Ueno T, Fujisawa JI, Sato Y, Suzuki T, Hasegawa H, Tokunaga M, Satou Y, Yasunaga JI, Matsuoka M, Utsunomiya A, Suzu S.

M-Sec induced by HTLV-1 mediates an efficient viral transmission.

PLoS Pathog 17(11):e1010126,2021.  doi: 10.1371/journal.ppat.1010126.

https://pubmed.ncbi.nlm.nih.gov/34843591/

Tanaka T, Nakamae H, Ito A, Fuji S, Hirose A, Eto T, Henzan H, Takase K, Yamasaki S, Makiyama J, Moriuchi Y, Choi I, Nakano N, Hiramoto N, Kato K, Sato T, Sawayama Y, Kim SW, Inoue Y, Inamoto Y, Fukuda T.

A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/Lymphoma.

Transplant Cell Ther 27(11):928 e1-e7,2021.doi: 10.1016/j.jtct.2021.07.010

https://pubmed.ncbi.nlm.nih.gov/34274491/

Kenji Maeda, Masayuki Amano, Yukari Uemura, Kiyoto Tsuchiya, Tomoko Matsushima, Kenta Noda, Yosuke Shimizu, Asuka Fujiwara, Yuki Takamatsu, Yasuko Ichikawa, Hidehiro Nishimura, Mari Kinoshita, Shota Matsumoto, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Shin-Ichi Oka, Ayako Mikami, Wataru Sugiura, Toshiyuki Sato, Tomokazu Yoshida, Shinya Shimada, Hiroaki Mitsuya.

Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals.

Sci Rep. 2021 Nov 24;11(1):22848. doi: 10.1038/s41598-021-01930-y.

https://pubmed.ncbi.nlm.nih.gov/34819514/